These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33299996)

  • 21. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR structures and localization of the potential fusion peptides and the pre-transmembrane region of SARS-CoV: Implications in membrane fusion.
    Mahajan M; Bhattacharjya S
    Biochim Biophys Acta; 2015 Feb; 1848(2):721-30. PubMed ID: 25475644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the pre-hairpin intermediate of the spike protein.
    Yang K; Wang C; Kreutzberger AJB; Ojha R; Kuivanen S; Couoh-Cardel S; Muratcioglu S; Eisen TJ; White KI; Held RG; Subramanian S; Marcus K; Pfuetzner RA; Esquivies L; Doyle CA; Kuriyan J; Vapalahti O; Balistreri G; Kirchhausen T; Brunger AT
    bioRxiv; 2022 Aug; ():. PubMed ID: 35982670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
    Trigueiro-Louro J; Correia V; Figueiredo-Nunes I; Gíria M; Rebelo-de-Andrade H
    Comput Struct Biotechnol J; 2020; 18():2117-2131. PubMed ID: 32913581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Disulfide Bridge on the Binding of SARS-CoV-2 Fusion Peptide to Cell Membrane: A Coarse-Grained Study.
    Shen H; Wu Z
    ACS Omega; 2022 Oct; 7(41):36762-36775. PubMed ID: 36278087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour.
    Sofia F Oliveira A; Shoemark DK; Avila Ibarra A; Davidson AD; Berger I; Schaffitzel C; Mulholland AJ
    Comput Struct Biotechnol J; 2022; 20():139-147. PubMed ID: 34934478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The flexibility of ACE2 in the context of SARS-CoV-2 infection.
    Barros EP; Casalino L; Gaieb Z; Dommer AC; Wang Y; Fallon L; Raguette L; Belfon K; Simmerling C; Amaro RE
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein.
    Remington JM; McKay KT; Ferrell JB; Schneebeli ST; Li J
    Biophys J; 2021 Jul; 120(14):2848-2858. PubMed ID: 34087207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
    Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
    Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.